Literature DB >> 27057006

Reducing Hepatocyte Injury and Necrosis in Response to Paracetamol Using Noncoding RNAs.

Dagmara Szkolnicka1, Baltasar Lucendo-Villarin1, Joanna K Moore1, Kenneth J Simpson2, Stuart J Forbes1, David C Hay3.   

Abstract

UNLABELLED: The liver performs multiple functions within the human body. It is composed of numerous cell types, which play important roles in organ physiology. Our study centers on the major metabolic cell type of the liver, the hepatocyte, and its susceptibility to damage during drug overdose. In these studies, hepatocytes were generated from a renewable and genetically defined resource. In vitro-derived hepatocytes were extensively profiled and exposed to varying levels of paracetamol and plasma isolated from liver-failure patients, with a view to identifying noncoding microRNAs that could reduce drug- or serum-induced hepatotoxicity. We identified a novel anti-microRNA, which reduced paracetamol-induced hepatotoxicity and glutathione depletion. Additionally, we identified a prosurvival role for anti-microRNA-324 following exposure to plasma collected from liver failure patients. We believe that these studies represent an important advance for the field, demonstrating the power of stem cell-derived systems to model human biology "in a dish" and identify novel noncoding microRNAs, which could be translated to the clinic in the future. SIGNIFICANCE: The liver performs vital functions within the human body and is composed of numerous cell types. The major metabolic cell type of the liver, the hepatocyte, is susceptible to damage during drug overdose. In these studies, hepatocytes were generated from a renewable resource and exposed to varying levels of paracetamol, with a view to identifying interventions that could reduce or attenuate drug-induced liver toxicity. A novel noncoding RNA that reduced paracetamol-induced hepatocyte toxicity was identified. These findings may represent an important advance for the field. ©AlphaMed Press.

Entities:  

Keywords:  Apoptosis; Drug-induced liver injury; Hepatocyte; MicroRNA; Necrosis; Paracetamol

Mesh:

Substances:

Year:  2016        PMID: 27057006      PMCID: PMC4878326          DOI: 10.5966/sctm.2015-0117

Source DB:  PubMed          Journal:  Stem Cells Transl Med        ISSN: 2157-6564            Impact factor:   6.940


  40 in total

1.  Estimates of acetaminophen (Paracetomal)-associated overdoses in the United States.

Authors:  Parivash Nourjah; Syed Rizwanuddin Ahmad; Claudia Karwoski; Mary Willy
Journal:  Pharmacoepidemiol Drug Saf       Date:  2006-06       Impact factor: 2.890

2.  MicroRNA targeting specificity in mammals: determinants beyond seed pairing.

Authors:  Andrew Grimson; Kyle Kai-How Farh; Wendy K Johnston; Philip Garrett-Engele; Lee P Lim; David P Bartel
Journal:  Mol Cell       Date:  2007-07-06       Impact factor: 17.970

3.  MicroRNAs play a role in the development of human hematopoietic stem cells.

Authors:  Rongxia Liao; Jianguo Sun; Liang Zhang; Guiyu Lou; Min Chen; Dujin Zhou; Zhengtang Chen; Shaoxiang Zhang
Journal:  J Cell Biochem       Date:  2008-06-01       Impact factor: 4.429

4.  MicroRNA regulates the expression of human cytochrome P450 1B1.

Authors:  Yuki Tsuchiya; Miki Nakajima; Shingo Takagi; Takao Taniya; Tsuyoshi Yokoi
Journal:  Cancer Res       Date:  2006-09-15       Impact factor: 12.701

5.  The impact of microRNAs on protein output.

Authors:  Daehyun Baek; Judit Villén; Chanseok Shin; Fernando D Camargo; Steven P Gygi; David P Bartel
Journal:  Nature       Date:  2008-07-30       Impact factor: 49.962

Review 6.  Acute liver failure including acetaminophen overdose.

Authors:  Robert J Fontana
Journal:  Med Clin North Am       Date:  2008-07       Impact factor: 5.456

7.  Regulation of ABCG2 expression at the 3' untranslated region of its mRNA through modulation of transcript stability and protein translation by a putative microRNA in the S1 colon cancer cell line.

Authors:  Kenneth K W To; Zhirong Zhan; Thomas Litman; Susan E Bates
Journal:  Mol Cell Biol       Date:  2008-06-23       Impact factor: 4.272

8.  Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells.

Authors:  Hua Zhu; Hao Wu; Xiuping Liu; Brad R Evans; Daniel J Medina; Chang-Gong Liu; Jin-Ming Yang
Journal:  Biochem Pharmacol       Date:  2008-06-24       Impact factor: 5.858

9.  Highly efficient differentiation of hESCs to functional hepatic endoderm requires ActivinA and Wnt3a signaling.

Authors:  David C Hay; Judy Fletcher; Catherine Payne; John D Terrace; Ronald C J Gallagher; Jan Snoeys; James R Black; Davina Wojtacha; Kay Samuel; Zara Hannoun; Anne Pryde; Celine Filippi; Ian S Currie; Stuart J Forbes; James A Ross; Philip N Newsome; John P Iredale
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-21       Impact factor: 11.205

10.  Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin.

Authors:  Olga Kovalchuk; Jody Filkowski; James Meservy; Yaroslav Ilnytskyy; Volodymyr P Tryndyak; Vasyl' F Chekhun; Igor P Pogribny
Journal:  Mol Cancer Ther       Date:  2008-07       Impact factor: 6.261

View more
  18 in total

1.  miRNA-324, a potential therapeutic target for paracetamol-induced liver injury.

Authors:  Hong Min Wu; Sang Geon Kim
Journal:  Stem Cell Investig       Date:  2016-10-25

2.  Noncoding RNAs as therapeutics for acetaminophen-induced liver injury.

Authors:  Benjamin L Woolbright; Hartmut Jaeschke
Journal:  Stem Cell Investig       Date:  2016-10-11

3.  A Drug Screen using Human iPSC-Derived Hepatocyte-like Cells Reveals Cardiac Glycosides as a Potential Treatment for Hypercholesterolemia.

Authors:  Max A Cayo; Sunil K Mallanna; Francesca Di Furio; Ran Jing; Lauren B Tolliver; Matthew Bures; Amanda Urick; Fallon K Noto; Evanthia E Pashos; Matthew D Greseth; Maciej Czarnecki; Paula Traktman; Wenli Yang; Edward E Morrisey; Markus Grompe; Daniel J Rader; Stephen A Duncan
Journal:  Cell Stem Cell       Date:  2017-04-06       Impact factor: 24.633

4.  Mapping the miRNA-mRNA Interactome in Human Hepatocytes and Identification of Functional mirSNPs in Pharmacogenes.

Authors:  Nicholas R Powell; Harrison Zhao; Joseph Ipe; Yunlong Liu; Todd C Skaar
Journal:  Clin Pharmacol Ther       Date:  2021-08-13       Impact factor: 6.903

5.  Prediction of Differentiation Tendency Toward Hepatocytes from Gene Expression in Undifferentiated Human Pluripotent Stem Cells.

Authors:  Kana Yanagihara; Yujung Liu; Kei Kanie; Kazuo Takayama; Minako Kokunugi; Mitsuhi Hirata; Takayuki Fukuda; Mika Suga; Hiroki Nikawa; Hiroyuki Mizuguchi; Ryuji Kato; Miho K Furue
Journal:  Stem Cells Dev       Date:  2016-11-08       Impact factor: 3.272

6.  Lipidomic profiling of patient-specific iPSC-derived hepatocyte-like cells.

Authors:  Mostafa Kiamehr; Leena E Viiri; Terhi Vihervaara; Kaisa M Koistinen; Mika Hilvo; Kim Ekroos; Reijo Käkelä; Katriina Aalto-Setälä
Journal:  Dis Model Mech       Date:  2017-07-21       Impact factor: 5.758

Review 7.  Drug-Induced Liver Injury: Cascade of Events Leading to Cell Death, Apoptosis or Necrosis.

Authors:  Andrea Iorga; Lily Dara; Neil Kaplowitz
Journal:  Int J Mol Sci       Date:  2017-05-09       Impact factor: 5.923

Review 8.  Pluripotent stem cell derived hepatocytes: using materials to define cellular differentiation and tissue engineering.

Authors:  B Lucendo-Villarin; H Rashidi; K Cameron; D C Hay
Journal:  J Mater Chem B       Date:  2016-05-06       Impact factor: 6.331

Review 9.  Concise Review: Advances in Generating Hepatocytes from Pluripotent Stem Cells for Translational Medicine.

Authors:  Dagmara Szkolnicka; David C Hay
Journal:  Stem Cells       Date:  2016-04-22       Impact factor: 6.277

10.  Modelling foetal exposure to maternal smoking using hepatoblasts from pluripotent stem cells.

Authors:  Baltasar Lucendo-Villarin; Panagiotis Filis; Madeleine J Swortwood; Marilyn A Huestis; Jose Meseguer-Ripolles; Kate Cameron; John P Iredale; Peter J O'Shaughnessy; Paul A Fowler; David C Hay
Journal:  Arch Toxicol       Date:  2017-05-16       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.